Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00145301
Status:
COMPLETED
Last Update Posted:
2012-05-21
First Post:
2005-09-01
Brief Title:
52 Week International Multi-center Randomized Double-blind Double-dummy Parallel-group Clinical Trial to Compare Retention on Treatment Safety Tolerability Efficacy of Lumiracoxib 100 mg od Lumiracoxib 100 mg Bid Celecoxib 200 mg od in Pts With Primary OA of Hip Knee Hand or Spine
Sponsor:
Novartis
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Osteoarthritis |
Keywords:
| Name | View |
|---|---|
| Osteoarthritis lumiracoxib retention on treatment efficacy safety | View |